featured
OBSERVE-5: No New Safety Concerns for Etanercept in Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
OBSERVE-5: Observational Postmarketing Safety Surveillance Registry of Etanercept for the Treatment of Psoriasis Final 5-Year Results
J Am Acad Dermatol 2014 Sep 25;[EPub Ahead of Print], AB Kimball, KJ Rothman, G Kricorian, D Pariser, PS Yamauchi, A Menter, CF Teller, G Aras, NA Accortt, M Hooper, KC Rice, JM GelfandFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.